rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1994-4-8
|
pubmed:abstractText |
To evaluate the association of the level of soluble serum interleukin-2 receptor (sIL-2R) with disease activity and response to therapy in patients with rheumatoid arthritis (RA).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0004-3591
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
50-6
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8129764-Adult,
pubmed-meshheading:8129764-Aged,
pubmed-meshheading:8129764-Arthritis, Rheumatoid,
pubmed-meshheading:8129764-Female,
pubmed-meshheading:8129764-Humans,
pubmed-meshheading:8129764-Linear Models,
pubmed-meshheading:8129764-Male,
pubmed-meshheading:8129764-Methotrexate,
pubmed-meshheading:8129764-Middle Aged,
pubmed-meshheading:8129764-Receptors, Interleukin-2,
pubmed-meshheading:8129764-Regression Analysis
|
pubmed:year |
1994
|
pubmed:articleTitle |
Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate.
|
pubmed:affiliation |
Arthritis Unit of the Medical Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|